
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $4.3B | -- | -- | $2.66 | -- |
08/05/2025 | Q2 | $4.2B | -- | -- | $2.64 | -- |
05/06/2025 | Q1 | $4.1B | $4.2B | $2.77 | $2.50 | $0.27 |
02/11/2025 | Q4 | $4.1B | $4.4B | $2.12 | $2.28 | -$0.16 |
10/29/2024 | Q3 | $4.1B | $4.2B | $2.68 | $2.02 | $0.66 |
07/30/2024 | Q2 | $4.1B | $4.1B | $2.37 | $2.27 | $0.10 |
04/30/2024 | Q1 | $3.8B | $4B | $2.07 | $1.70 | $0.37 |
02/13/2024 | Q4 | $3.8B | $4B | $1.66 | $1.75 | -$0.09 |
10/31/2023 | Q3 | -- | -- | -$2.91 | $1.67 | -$4.58 |
08/01/2023 | Q2 | -- | -- | $1.50 | $1.57 | -$0.07 |
05/02/2023 | Q1 | -- | -- | $1.17 | $1.59 | -$0.42 |
02/14/2023 | Q4 | -- | -- | $1.28 | $1.61 | -$0.33 |
11/01/2022 | Q3 | -- | -- | $1.17 | $1.57 | -$0.40 |
08/02/2022 | Q2 | -- | -- | $1.24 | $1.56 | -$0.32 |
05/03/2022 | Q1 | -- | -- | $1.25 | -- | -- |
02/15/2022 | Q4 | -- | -- | $1.23 | -- | -- |
11/02/2021 | Q3 | -- | -- | $1.43 | -- | -- |
08/03/2021 | Q2 | -- | -- | $1.18 | -- | -- |
05/04/2021 | Q1 | -- | -- | $1.42 | -- | -- |
02/23/2021 | Q4 | -- | -- | $1.37 | -- | -- |
11/02/2020 | Q3 | -- | -- | $1.13 | -- | -- |
08/04/2020 | Q2 | -- | -- | $1.06 | -- | -- |
05/05/2020 | Q1 | -- | -- | $0.80 | -- | -- |
02/18/2020 | Q4 | -- | -- | $1.26 | -- | -- |
10/29/2019 | Q3 | -- | -- | $1.11 | -- | -- |
07/30/2019 | Q2 | -- | -- | $0.93 | -- | -- |
04/30/2019 | Q1 | -- | -- | $1.29 | -- | -- |
02/19/2019 | Q4 | -- | -- | $1.25 | -- | -- |
10/25/2018 | Q3 | -- | -- | $0.96 | -- | -- |
07/26/2018 | Q2 | -- | -- | $0.94 | -- | -- |
05/03/2018 | Q1 | -- | -- | $0.66 | -- | -- |
02/22/2018 | Q4 | -- | -- | $0.74 | -- | -- |
11/02/2017 | Q3 | -- | -- | $0.53 | -- | -- |
07/06/2017 | Q2 | -- | -- | $0.64 | -- | -- |
05/04/2017 | Q1 | -- | -- | $0.47 | -- | -- |
02/23/2017 | Q4 | -- | -- | $0.39 | -- | -- |
11/03/2016 | Q3 | -- | -- | $0.80 | -- | -- |
07/28/2016 | Q2 | -- | -- | $0.55 | -- | -- |
04/27/2016 | Q1 | -- | -- | $0.66 | -- | -- |
02/18/2016 | Q4 | -- | -- | $0.78 | $0.66 | $0.12 |
10/29/2015 | Q3 | -- | -- | $0.67 | -- | -- |
Leidos Holdings reported $4.2B worth of top line sales in its most recent quarter.
Leidos Holdings announced earnings per share of $2.77 which represents a beat of analyst forecast a $2.50 per share.
Leidos Holdings reported $757M that represents $5.78 per share over the last quarter.
Leidos Holdings's earnings are forecast to grow from $9.22 per share to $10.12 per share next year representing an increase of 17.5%.
Leidos Holdings's next earnings date is August 5, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.